Edward Smith
0000-0003-0073-9377
2 papers found
Refreshing results…
Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study
Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug
Missing publications? Search for publications with a matching author name.